|
Gallimune 302 ND+IB+EDS
Contra-indications, warnings, etc
Keep out of reach of children.
For animal treatment only.
No information is available on the safety and efficacy from the concurrent use of this vaccine with any other. It is therefore recommended that no other vaccines should be administered within 14 days before or after vaccination with the product.
Only healthy animals should be vaccinated.
Apply the usual aseptic procedures when vaccinating.
Not recommended to be used within 2 weeks before the onset of lay and during the laying period.
No palpable reactions were observed following the injection of one dose of vaccine.
In clinical studies, lesions linked to the oily adjuvant were observed histologically three weeks after injection in 87% of cases, e.g. small quantities of oily residues and occasional aseptic micro-abscesses.
Transitory apathy and slight oedema at injection site may occur after administration of a double dose of vaccine.
USER SAFETY
To the user
This product contains mineral oil. Accidental injection/self-injection may result in severe pain and swelling, particularly if injected into a joint or finger, and in rare cases could result in the loss of the affected finger if prompt medical attention is not given.
If you are accidentally injected with this product, seek prompt medical advice even if only a very small amount is injected and take the package leaflet with you.
If pain persists for more than 12 hours after medical examination, seek medical advice again.
Hands should be washed after vaccinating.
To the physician
This product contains mineral oil. Even if small amounts have been injected, accidental injection with this product can cause intense swelling, which may, for example, result in ischaemic necrosis and even the loss of a digit. Expert, PROMPT, surgical attention is required and may necessitate early incision and irrigation of the injected area, especially where there is involvement of finger pulp or tendon.
Withdrawal periods
Zero days.
|
















